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=Abstract  =From the concepts of well known ototoxic effects of loop diuretics 
and hypoxic state, twenty anesthetized guinea pigs with diuretics and/or hypoxia 
were evaluated with click-evoked otoacoustic emissions (CEOAEs) by time- 
sequential monitoring. Furosemide 2 5  mg/kg was infused intravenously and 
CEOAEs were measured before and 5, 10, 20, 30, 45 and 60 minutes after 
injection in 8 guinea pigs. Both echo responses and reproducibilities were 
decreased significantly a t  10 minutes after injection and showed minimal level a t  
2 0  minutes. Recovery of CEOAEs was noted by spectral analysis a t  30 minutes 
after injection, and full recovery of CEOAEs was evident after then. At 60 
minutes after injection, hypoxia of 2 0  seconds by turning off the artificial 
respirator was added. The CEOAEs showed statistically significant decreases 
compared with those of prehypoxic state (p~0 .01) .  The CEOAEs of 8 guinea pigs 
with injection of furosemide. 50 mg/kg showed decreased responses and no 
recoveries for the 60 minutes observation periods. Findings from this study 
support the clinical utility of CEOAEs as a screening test for early detection of 
various ototoxicities. 
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of sound waves that were measured by a 
INTRODUCTION microphone inserted into the external ear. The 
presence of the EOAE provides evidence of a 
The evoked otoacoustic emission (EOAE) is functioning cochlea (Collet 1978; Stevens 1988). 
a reflection of the sound waves to a specific Thus it can be used as a functional cochleogram 
acoustic stimulus. It is generated from the that represents the physiology of the peripheral 
cochlea and emitted via ossicles and the sound processing mechanism (Kemp et a / .  
tympanic membrane retrogradely. In 1978, 1986). 
Kemp reported the presence of faint reflections The EOAE test can be performed without 
anesthesia in human subjects. What should be 
Kec,ei\.ccl March 1993, and in final form June 1993. 
considered first on measuring the click evoked 
tThis st~lili  was silplx)rtc~l h i  gut11 #9?-132 fmtll SCOLII N111011a1 OtOacOustic is  adequate 
Ilnlvenity Hospital fitting of the probe in the external ear canal. 
'.1%r;q%L-z C,l~! \ r ;Hq 0 ] ~ l ? ! T 4 ~ ~ 4 :  %?!2,%5\$! Addit ional changes in acoustic damping 
(electric impedance) of earprobe cause different 
characteristics of emissions (Zwicker 1990). 
Measuring of CEOAEs in guinea pigs was 
thought to be a difficult problem because of their 
short latency and duration. The authors' data on 
the profiles of the CEOAE findings in normal 
guinea pigs(1992) showed stable findings for 
test-retest reliability, even though the thresholds 
were higher than human ones. And the 
predominant response was shifted to higher 
frequencies according to the spectral analyses. 
Loop diuretics cause interstitial edema of 
stria vascularis and secondary hair cel l  
changes. These changes are reversible and 
occur in high dose intoxication (Quick and 
Duvall 1970; Kohonen and Janhidinen 1970). 
EOAEs could be  involved with reduction or 
elimination of its amplitude (Anderson and Kemp 
1979; Anderson 1980; Kemp and Brown 1984; 
Wilson and Evans 1983). Hypoxia also reduces 
the amplitude of OAE in laboratory animals (Kim 
1980; Schmidt and Adams 1981; Lonsbury- 
Martin et a/. 1987). Whether the ingestion of loop 
diuretics and the application of hypoxia have 
synergistic effects on the reduction of OAEs is 
not clear. 
This study was planned to evaluate the 
influence of furosemide and superimposed 
hypoxia on the profiles of the CEOAE. The 
hypoxic state was arti f icial ly created for 
evaluation of a synergistic insult to inner ear 
having al tered physiology by furosemide 
infusion. 
The primary intention of this study was to 
elucidate the efficacy of the CEOAE test as a 
surveillance index for detecting the effects of 
ototoxic drugs and toxic environments. 
animal which failed to show CEOAEs in a 
screening test was excluded from this study. 
Anesthesia was init iated with an 
intraperitoneal injection of sodium pentobarbital 
(Nembutal )  30 mg lkg .  The animal was 
tracheotomized in supine posit ion. After 
intramuscular injection of Myoblock (1 .25 
mglkg) ,  respiration was controlled with an 
artificial ventilator (Narishige) at the rate of 60 
timeslminute and 6-8 ml of tidal volume. Body 
temperature was maintained by convection heat 
from the surgical light. The total time of the 
experiment did not exceed 2 hours, so booster 
injections of the anesthetic agent were not 
necessary. After the experiment, the animal was 
sacrified immediately. , 
Measurement of the CEOAE 
This experiment was conducted using the 
IL088 Otodynamic Analyzer developed by Bray 
and Kemp (1987). The click stimuli elicited by 80 
psec electr ical  pulses were used with a 
frequency range of 0-6 kHz and an interstimulus 
repetition rate of 20 msec. Figure 1 shows the 
system block diagram used in this study. 
The infant-style ear probe containing an 
earphone and a microphone was connected to 
the amplifier and the averaging computer 
system. Tight fitting of the probe on the EAC is a 
very important step on measuring the CEOAE 
(Zwicker 1990). We performed this experiment in 
a noise shielded booth with the animal deeply 
anesthetized to minimize external and internal 
noise. The artificial ventilator was also placed out 
of the booth to minimize noise. 
Threshold for the noise level was set on the 
ILO 88 Otodynamic analyser hardware configuration 
MATERIALS AND METHODS 
S e l e c t i o n  a,nd m a n i p u l a t i o n  o f  t e s t  
animals 
Twenty albino guinea pigs weighing 250 to 
400 gm and having normal Preyer reflexes were 
used. The tympanic membrane was assessed to 
be normal under microscopic examination. Any 
-4 IBM PCiXTiAT [ Standard IBM PC bus I 
Storage media generator processor 
earphone microphone 
F i g. 1. System block diagram used in this study 
IBM PC and the CEOAE was measured using 
the standard setting of the IL088 (260 repetition, 
window from 2 .5  msec to 20 msec) .  The 
amplitude of echo response above 5 dB and the 
reproducibility above 50% were regarded as 
positive responses (Kemp 1990). 
In jec t ion  o f  fu rosemide  and i nduc t i on  
of hypox ia  
After the preparation of the animal, a small 
probe was fitted into the external ear canal of the 
guinea pig. Measurement of the CEOAE was 
started from 0 dB test gain (84 dB peak SPL). 
Sequential measurement of the CEOAE was 
done by ascending and descending the test 
gain by 5 dB steps and eventually determining 
the minimal threshold of the click that suffices 
the reference value of a posit ive CEOAE. 
Variable parameters manifested on the CEOAE 
at a given threshold level were compared with 
those in a different ototoxic environmental 
setting. The animals were divided into four 
groups (Table 1); 
First group: Respiration of four guinea pigs 
was halted by turning off the respirator for 100 
seconds and the CEOAE was measured 
immediately after the cessation of artificial 
respiration. 
Second group: The left internal jugular vein 
of eight guinea pigs was exposed surgically and 
25 mglkg of furosemide was infused. The 
CEOAE was checked 5, 10, 20, 30, 45, and 60 
minutes after the infusion of furosemide. These 
guinea pigs were exposed to 20 seconds of 
additional hypoxia, sixty minutes after the 
infusion of furosemide, and the CEOAE was 
checked again. 
Third group: Furosemide at a dosage of 50 
mglkg was infused into the eight guinea pigs as 
in the secoi:d group. The CEOAE was checked 
sequentially 5, 10, 20, 30, 45, and 60 minutes 
after the infusion. 
Stat is t ica l  analysis 
Statistical analysis was performed by the 
SAS program. The clinical significance of the 
experiment was tested with the Wilcox signed 
rank test within p value of 0.01 
RESULTS 
The CEOAE f indings under the hypox ic  
env i ronment 
The threshold level of the CEOAE was 
checked in the first group (four guinea pigs). 
After identifying the threshold, the artificial 
ventilator was disconnected for 100 seconds 
and the CEOAE at the preset threshold level was 
checked right after the hypoxic event. 
The hypoxic state for 100 seconds proved to 
have no statistically significant impact on the 
profiles of the CEOAE. One example is displayed 
in Figure 2. Both amplitude of echo response 
and reproducibility did not show any significant 
change. 
The CEOAE f i nd ings  af ter  exposure to 
f u rosem i de. 
The ampli tude of echo responses and 
reproducibility of the second group (eight guinea 
p igs )  which were infused with 25 mg lkg  
furosemide showed decreased parameters from 
10 minutes to 45 minutes (p<0 .01) .  The 
amplitude and the reproducibility of the CEOAE 
were decreased from 10 minutes after infusion, 
to their lowest value at 20 minutes after infusion, 
and recovered to pre-infusion levels by 45 and 
60 minutes after infusion (Fig. 3). Panel A in Fig. 
Table 1. Groups of experimental animals (N=20 guinea pigs) 
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Am: 13.4 dB, R: 75% 
Am: 13.6 dB. R. 73% 
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Fig. 2. Time domain responses of CEOAEs to 20 dB 
test gain (104 dB pSPL) click stimuli before (A) 
and after (B) the hypoxic exposure for 100 
seconds in a guinea pig. Am: Amplitude, R :  
Reproducibility 
3 shows the changes in the amplitude of echo 
response of 8 guinea pigs and panel B shows 
the changes of the reproducibility. Panel C plots 
the changes in both measures,with the horizontal 
plane indicating the amplitude of echo response 
and the vert ical  plane indicat ing the 
reproducibility. 
The echo response and the reproducibility 
in the CEOAE of the 8 guinea pigs which were 
infused with 50 mglkg furosemide (the third 
group) showed statistically significant decrease 
right after the exposure. There was no evidence 
of recovery of the echo response and the 
reproducibility after 60 minutes had passed 
(p<0.01). Fig. 4 depicts the CEOAE findings of 
the third group 
A d d i t i v e  e f f e c t  o f  h y p o x i a  o n  t h e  
furosemide in fus ion 
The variables in the CEOAE were normal at 
60 minutes after the exposure to the furosemide 
at 25 mglkg. Additional exposure to the hypoxia 
for 20 seconds after recovery from the 
furosemide infusion resulted in dysmotility of 
cardiac contraction during the hypoxic event. 
Profiles of the CEOAE immediately after the 
combined exposure revealed a statistically 
signif icant addit ive decrease in the echo 
response and the reproducibility than those 
caused by the separate exposures (p<0.01). 
Figure 4 displays the results of the additive insult 
of hypoxia in animals receiving furosemide (25 
mglkg). 
DISCUSSION 
In this study, a deep anesthesia was 
maintained with the artificial ventilator via the 
tracheotomy tube to minimize noise from the test 
animal. Deep anesthesia was also necessary to 
maintain access with the intravenous drug- 
administration route. 
We used the small s ized probe t ip  
commercialized by Otodynamics Ltd. This probe 
tip had the merit of superior detection capability 
of high frequency emission above 3 kHz and 
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Fig. 3. Click evoked otoacoustic emissions in furosemide 25 mg/kg group (8 guinea pigs) to the given threshold 
level of click stimuli. Panel A: time domain changes of echo amplitude, B: time domain changes of 
reproducibility, C: amplitude and reproducibility 
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Fig. 4. Click evoked otoacoustic emissions in furosemide 50 mglkg group (8 guinea pigs) to the given threshold 
level of click stimuli. Panel A:  time domain changes of echo amplitude, B: time domain changes of 
reproducibility, C: amplitude and reproducibiliity. 
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subjects, but they have homogenous features for 
the same subjects that were tested at different 
times under the same stimulus intensity (Kemp 
et a / .  1986). Positive echo responses were 
regarded as funct ioning outer hair cel ls ,  
especially within middle frequency region (Collet 
et a/. 1989). 
The CEOAE has a benefit of early detection 
capability of cochlear lesion, e.g any disease 
process, change due to exposure to noise, and 
exposure to ototoxic drugs. Temporary threshold 
shift after exposure to noise has been recorded 
objectively with the CEOAE in human subjects 
- 2 0  
F ig.  5. Click evoked otoacoustic emissions in (Zurek 1985; Kemp et a/ .  1989). With ototoxic 
furosemide 25 mglkg group with hypoxia for 20 drugs, the initial decrease and the gradual 
seconds at the end of 60 minutes' observation 
period (8 guinea pigs, same group as Figure 3) recovery of the echo response of the CEOAE 
A 
- .  
to the threshold level of click stimuli. have variable time intervals according to the kind 
of drug, that had already been previously 
capability of eliminating the distortion of the 
response by the stimulus itself (Kemp et a/ .  
1986). The fitting procedure must not be so 
complete as that of the tympanometry test, but 
the noise should be restricted to an adequate 
level for a significant test. In this study, malleable 
silicon rubber sealing was applied around the tip 
to promote the correct fitting to the ear canal. 
The tip of the probe must be directed to the 
tympanic membrane without being blunted 
against the canal walls (Kemp 1986; Kim 1980; 
Bonfils and Uziel 1989; Bonfils et a/. 1989). 
The profiles of the CEOAE vary with different 
observed in patas monkeys in which loop 
diuretics had been infused (Zurek 1985; Kemp 
et a/. 1 989). 
The ototoxic effect of furosemide and 
hypoxia had been a proven cochlear 
manipulation method by many authors, but the 
effects on CEOAEs were not common. So these 
were selected as the test materials for evaluation 
of the ototoxic effect manifested in the changes 
of the CEOAE. 
Hypoxic state made with cessation of 
re,spiration for a period of 100 seconds in 4 
guinea pigs had no statistically significant 
influence on the CEOAE. 
For the grljnea pigs that were infused with 
50 mglkg of fuljsemide, the variable parameters 
of the CEOAE were decreased immediately after 
the infusion and there was no evidence of 
recovery even after 60 minutes had passed. The 
other group exposed to furosemide at 25 mglkg 
concentration had decreased parameters of the 
CEOAE and the lowest value at 20 minutes after 
the infusion. They began to recover from 30 
minutes after the infusion and normalized to the 
previous level around 45 minutes after the 
infusion. These were tested with the Wilcoxon 
signed rank test and were statistically significant 
(p < 0.01). 
The CEOAE profiles to an additive toxicity of 
the hypoxia on the loop diuretics could be 
deduced from the fact that additional exposure 
of the hypoxia immediately after the recovery 
from the ototoxic loop diuretic insult resulted in a 
more statistically significant decrease of the 
variables of the CEOAE than that of separate 
exposure to the ototoxic drug.  Further 
comparat ive study with conventional 
acousticophysiological measures is mandatory 
to determine the underlying processes 
responsible for the synergistic effect. 
The CEOAE, as one of the responses of the 
peripheral sense organ, has a perspective of 
developing into a functional cochleogram for 
evaluating cochlear lesions (Kemp et a/. 1986; 
Bonfils and Uziel 1989; Bonfils et a/ .  1989). 
Changes in the echo level may not be a sign for 
differential diagnosis of cochlear pathology, but it 
remains as a subject of further study. 
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